{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T19:56:14Z","timestamp":1774036574428,"version":"3.50.1"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Susan G Komen Foundation"},{"DOI":"10.13039\/100000054","name":"US National Cancer Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Rossy Family Foundation"},{"DOI":"10.13039\/501100004099","name":"La Ligue Contre le Cancer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swiss Cancer League"},{"DOI":"10.13039\/501100013362","name":"Swiss Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006505","name":"Swiss Re","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Japanese Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["23EA1033"],"award-info":[{"award-number":["23EA1033"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We assessed survival trends and international comparisons of patients with cutaneous melanoma from Japanese regional population-based cancer registries participating in the CONCORD-3 study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Subjects were patients aged 15\u201399\u00a0years diagnosed with cutaneous melanoma during 2000\u20132014, with follow-up completed either 5\u00a0years after diagnosis or through 31 December 2014. Five-year net survival was estimated by morphological type and calendar period of diagnosis, using the Pohar Perme estimator, and age-standardized using the International Cancer Survival Standard weights.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Age-standardized 5-year net survival for cutaneous melanoma remained stable among 4018 eligible subjects as follows: 68.9% during 2000\u20132004 (862 patients), 68.3% during 2005\u20132009 (1819 patients), and 69.0% during 2010\u20132014 (1337 patients). Five-year net survival in 2010\u20132014 was highest for lentigo maligna melanoma (89.0%, 64 patients, not age-standardized), followed by superficial spreading melanoma (88.4%, 91 patients) and acral lentiginous melanoma (83.7%, 163 patients, not age-standardized). However, survival for malignant melanoma not otherwise specified (68.0%, 1120 patients) and nodular melanoma was lower (56.5%, 58 patients). Five-year net survival for all types of cutaneous melanoma combined during 2010\u20132014 was lower in Japan (69.0%) and South Korea (59.9%) than in Australia, France, Germany, Italy, UK, Canada and the US (&amp;gt;85.7%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>International disparities in net survival for cutaneous melanoma may be attributable to differences in the distribution of histological sub-types of melanoma and to variation in the availability and utilization of treatment modalities. Continuous monitoring of cancer survival is crucial for developing effective cancer control strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jjco\/hyaf019","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T07:14:00Z","timestamp":1737530040000},"page":"i64-i72","source":"Crossref","is-referenced-by-count":1,"title":["Trends in net survival of patients with cutaneous melanoma in Japan, 2000\u201314 (CONCORD-3)"],"prefix":"10.1093","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2536-0865","authenticated-orcid":false,"given":"Hiromi","family":"Sugiyama","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Radiation Effects Research Foundation , 5-2, Hijiyama Park, Minami-ku, Hiroshima, Hiroshima , 732-0815,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7244-9526","authenticated-orcid":false,"given":"Veronica","family":"Di Carlo","sequence":"additional","affiliation":[{"name":"Cancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine , Keppel Street, London , WC1E 7HT,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Matz","sequence":"additional","affiliation":[{"name":"Cancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine , Keppel Street, London , WC1E 7HT,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5200-9310","authenticated-orcid":false,"given":"Izumi","family":"Oki","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Saitama Prefectural University , 820 Sannomiya, Koshigaya, Saitama, 343-8540 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Shibata","sequence":"additional","affiliation":[{"name":"Yamagata Prefectural Central Hospital, 1800 Oaza-Aoyanagi, Yamagata , Yamagata, 990-2214 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9782-8637","authenticated-orcid":false,"given":"Kayo","family":"Nakata","sequence":"additional","affiliation":[{"name":"Cancer Control Center, Osaka International Cancer Institute , 3-1-69 Otemae, Chuo-ku, Osaka city, Osaka, 541-8567,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3708-5039","authenticated-orcid":false,"given":"Mari K","family":"Saito","sequence":"additional","affiliation":[{"name":"Cancer Control Center, Osaka International Cancer Institute , 3-1-69 Otemae, Chuo-ku, Osaka city, Osaka, 541-8567,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8199-3037","authenticated-orcid":false,"given":"Masashi","family":"Matsuzaka","sequence":"additional","affiliation":[{"name":"Hirosaki University Hospital , 53, Honcho, Hirosaki, Aomori, 036-8563 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0712-2505","authenticated-orcid":false,"given":"Marisa","family":"Nishio","sequence":"additional","affiliation":[{"name":"Division of Prevention, National Cancer Center , 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 ,","place":["Japan"]},{"name":"Department of Medical Statistics , Faculty of Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka 569-8686,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0762-1147","authenticated-orcid":false,"given":"Isao","family":"Oze","sequence":"additional","affiliation":[{"name":"Aichi Cancer Center Research Institute , 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6155-5283","authenticated-orcid":false,"given":"Kaname","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Cancer Prevention and Control Division, Kanagawa Cancer Center Research Institute , 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa, 241-8515 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4626-0644","authenticated-orcid":false,"given":"Rina","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Hirosaki University Graduate School of Medicine , 5, Zaifucho, Hirosaki, Aomori, 036-8562 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0331-3235","authenticated-orcid":false,"given":"Laureline","family":"Gatellier","sequence":"additional","affiliation":[{"name":"Division of International Health Policy Research, Institute for Cancer Control, National Cancer Center , 5-1-1 Tsukiji, Chuo-ku, Tokyo , 104-0045,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5234-0507","authenticated-orcid":false,"given":"Isao","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Hematologic Oncology, NHO Shikoku Cancer Center , Minamiumenomoto-cho, Matsuyama, Ehime , 791-0280,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8023-4581","authenticated-orcid":false,"given":"Hidemi","family":"Ito","sequence":"additional","affiliation":[{"name":"Aichi Cancer Center Research Institute , 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7922-1871","authenticated-orcid":false,"given":"Norihiro","family":"Teramoto","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention and Epidemiology, Center for Cancer Research, Shikoku Cancer Center , Minamiumenomoto-cho, Matsuyama, Ehime, 791-0280 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention and Epidemiology, Center for Cancer Research, Shikoku Cancer Center , Minamiumenomoto-cho, Matsuyama, Ehime, 791-0280 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Kaizaki","sequence":"additional","affiliation":[{"name":"Fukui Prefectural Hospital , 2-8-1 Yotsui, Fukui, Fukui, 910-8526 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumitaka","family":"Moki","sequence":"additional","affiliation":[{"name":"Gunma Health Foundation , 16-1 Horinoshita-machi, Maebashi, Gunma, 371-0005 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuki","family":"Kurosawa","sequence":"additional","affiliation":[{"name":"Ibaraki Prefectural Office , 978-47, Kasahara-cho, Mito, Ibaraki, 310-0852 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Nemoto","sequence":"additional","affiliation":[{"name":"Ibaraki Pharmaceutical Association Inspection Center , 978-47, Kasahara-cho, Mito, Ibaraki, 310-0852 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0383-4911","authenticated-orcid":false,"given":"Hiroto","family":"Narimatsu","sequence":"additional","affiliation":[{"name":"Cancer Prevention and Control Division, Kanagawa Cancer Center Research Institute , 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa, 241-8515 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0454-0322","authenticated-orcid":false,"given":"Seiki","family":"Kanemura","sequence":"additional","affiliation":[{"name":"Miyagi Cancer Center Research Institute , 47-1 Nodayama, Medeshima-Shiode, Natori, Miyagi, 981-1293 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Miyashiro","sequence":"additional","affiliation":[{"name":"Cancer Control Center, Osaka International Cancer Institute , 3-1-69 Otemae, Chuo-ku, Osaka city, Osaka, 541-8567,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Mori","sequence":"additional","affiliation":[{"name":"Saga-ken Medical Centre Koseikan , 400 Nakabaru, Kasemachi, Saga, 840-8571 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Fujita","sequence":"additional","affiliation":[{"name":"Tochigi Cancer Center , 4-9-13, Yohnan, Utsunomiya, Tochigi, 320-0834 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7311-1233","authenticated-orcid":false,"given":"Tomohiro","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Division of International Health Policy Research, Institute for Cancer Control, National Cancer Center , 5-1-1 Tsukiji, Chuo-ku, Tokyo , 104-0045,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8940-3807","authenticated-orcid":false,"given":"Michel P","family":"Coleman","sequence":"additional","affiliation":[{"name":"Cancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine , Keppel Street, London , WC1E 7HT,","place":["United Kingdom"]},{"name":"Cancer Division , University College London Hospitals NHS Foundation Trust, 250 Euston Road, London, NW1 2PG, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4871-3766","authenticated-orcid":false,"given":"Claudia","family":"Allemani","sequence":"additional","affiliation":[{"name":"Cancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine , Keppel Street, London , WC1E 7HT,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"2026032004352607300_ref1","volume-title":"Number of incident cases and cancer incidence in 2020","author":"National Cancer Registry"},{"key":"2026032004352607300_ref2","volume-title":"Number of deaths","author":"Statistics"},{"key":"2026032004352607300_ref3","article-title":"Global cancer observatory: Cancer today (version 1.1). Lyon","author":"Ferlay","journal-title":"France: Int Agency Res Cancer"},{"key":"2026032004352607300_ref4","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.14924\/dermatol.117.1855","article-title":"Japanese guidelines for skin cancers (in Japanese)","volume":"117","author":"Saida","year":"2007","journal-title":"Japanese J Dermatol"},{"key":"2026032004352607300_ref5","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): Analysis of individual records for 37\u2008513\u2008025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"2026032004352607300_ref6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/bjd.21274","article-title":"Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1\u200a578\u200a482 adults diagnosed during 2000\u20132014 in 59 countries (CONCORD-3)*","volume":"187","author":"Di Carlo","year":"2022","journal-title":"Br J Dermatol"},{"key":"2026032004352607300_ref7","article-title":"Time series time series 2000 - 2020. Ministry of Internal Affairs and Communications","author":"","journal-title":"Portal Site Off Stat Japan"},{"key":"2026032004352607300_ref8","volume-title":"International classification of disease for oncology","author":"Fritz","year":"2000","edition":"Third"},{"key":"2026032004352607300_ref9","volume-title":"SEER summary staging manual - 2000: Codes and coding instructions","author":"Young","year":"2001"},{"key":"2026032004352607300_ref10","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1016\/j.ejca.2015.07.039","article-title":"Survival of patients with skin melanoma in Europe increases further: Results of the EUROCARE-5 study","volume":"51","author":"Crocetti","year":"2015","journal-title":"Eur J Cancer"},{"key":"2026032004352607300_ref11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1541-0420.2011.01640.x","article-title":"On estimation in relative survival","volume":"68","author":"Pohar Perme","year":"2012","journal-title":"Biometrics"},{"key":"2026032004352607300_ref12","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/(SICI)1097-0142(19961101)78:9&lt;2004::AID-CNCR23&gt;3.0.CO;2-#","article-title":"An alternative approach to monitoring cancer patient survival","volume":"78","author":"Brenner","year":"1996","journal-title":"Cancer"},{"key":"2026032004352607300_ref13"},{"key":"2026032004352607300_ref14"},{"key":"2026032004352607300_ref15"},{"key":"2026032004352607300_ref16","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1186\/s12889-015-2534-3","article-title":"Multivariable flexible modelling for estimating complete, smoothed life tables for sub-national populations","volume":"15","author":"Rachet","year":"2015","journal-title":"BMC Public Health"},{"key":"2026032004352607300_ref17","article-title":"Life tables for the CONCORD programme","author":"Di Carlo","year":"2018"},{"key":"2026032004352607300_ref18","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1016\/j.ejca.2004.07.002","article-title":"Standard cancer patient population for age standardising survival ratios","volume":"40","author":"Corazziari","year":"2004","journal-title":"Eur J Cancer"},{"key":"2026032004352607300_ref19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/1536867x1401400107","article-title":"Net survival estimation with stns","volume":"14","author":"Clerc-Urm\u00e8s","year":"2014","journal-title":"Stata J"},{"key":"2026032004352607300_ref20","volume-title":"Ministry of Health, Labour and Welfare","author":"Basic Plan to Promote Cancer Control Programs (in Japanese)"},{"key":"2026032004352607300_ref21","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.21873\/anticanres.14266","article-title":"Elderly age is associated with more conservative treatment of invasive melanoma","volume":"40","author":"Bateni","year":"2020","journal-title":"Anticancer Res"},{"key":"2026032004352607300_ref22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/1346-8138.15151","article-title":"Japanese dermatological association guidelines: Outlines of guidelines for cutaneous melanoma 2019","volume":"47","author":"Nakamura","year":"2020","journal-title":"J Dermatol"},{"key":"2026032004352607300_ref23","author":"dacarbazine injection 100"},{"key":"2026032004352607300_ref24","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1002\/cam4.2110","article-title":"Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma","volume":"8","author":"Fujisawa","year":"2019","journal-title":"Cancer Med"},{"key":"2026032004352607300_ref25","doi-asserted-by":"publisher","first-page":"e0286538","DOI":"10.1371\/journal.pone.0286538","article-title":"The role of histological subtypes in the survival of patients diagnosed with cutaneous or mucosal melanoma in the United States of America","volume":"18","author":"Tabatabai","year":"2023","journal-title":"PloS One"},{"key":"2026032004352607300_ref26","first-page":"3","article-title":"Recent advances in melanoma research","volume":"55","author":"Takata","year":"2007","journal-title":"Shinshu Med J (in Japanese)"},{"key":"2026032004352607300_ref27","volume-title":"Pharmaceuticals and medical devices agency","author":"Nivolmab"},{"key":"2026032004352607300_ref28","volume-title":"Pharmaceuticals and medical devices agency","author":"Ipilimumab"},{"key":"2026032004352607300_ref29","volume-title":"Pharmaceuticals and medical devices agency","author":"Pembrolizumab"},{"key":"2026032004352607300_ref30","volume-title":"Pharmaceuticals and medical devices agency","author":"Vemurafenib"},{"key":"2026032004352607300_ref31","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/1346-8138.17068","article-title":"Optimal strategy in managing advanced melanoma","volume":"51","author":"Uchi","year":"2024","journal-title":"J Dermatol"},{"key":"2026032004352607300_ref32","volume-title":"Drugs@FDA-approved drugs","author":"Zelboraf"},{"key":"2026032004352607300_ref33","volume-title":"European medicines agency","author":"Zelboraf"},{"key":"2026032004352607300_ref34","author":"Yervoy"},{"key":"2026032004352607300_ref35","volume-title":"European medicines agency","author":"Yervoy"},{"key":"2026032004352607300_ref36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.14924\/dermatol.125.5","article-title":"Japanese guidelines for skin cancers (2nd edition) (in Japanese)","volume":"125","author":"Tsuchida","year":"2015","journal-title":"Japanese J Dermatol"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/56\/Supplement_1\/i64\/67423406\/hyaf019.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/56\/Supplement_1\/i64\/67423406\/hyaf019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T08:35:38Z","timestamp":1773995738000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/56\/Supplement_1\/i64\/8529746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":36,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2026,3,20]]},"published-print":{"date-parts":[[2026,3,20]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyaf019","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,3]]}}}